Pharmaceuticals

Oral Solid Dosage Pharmaceutical Formulation Industry Forecast to Hit $810.94 Billion by 2029 With a Strong 5.6% CAGR

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Oral Solid Dosage Pharmaceutical Formulation Market Size During 2025–2029?

The oral solid dosage pharmaceutical formulation market size has experienced robust expansion in recent years. It is anticipated to grow from $618.34 billion in 2024 to $653.26 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.6%. This historical increase can be attributed to several factors including the rising prevalence of chronic diseases, an aging global population, wider access to healthcare, the promotion of generic formulations, and evolving consumer preferences.

Significant expansion is anticipated for the oral solid dosage pharmaceutical formulation market size over the coming years. This market is projected to reach $810.94 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.6%. Contributing factors to this growth during the forecast period include the increasing demand for personalized medicine, wider adoption of controlled-release technologies, a sharpened focus on biopharmaceuticals, the expansion into emerging markets, and shifts in policy and reimbursement frameworks. Furthermore, key trends expected during this period encompass the increasing adoption of personalized medicine, greater integration of digital health, the proliferation of telemedicine services, an enhanced focus on preventive healthcare, and the ongoing spread of artificial intelligence within the healthcare sector.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15626&type=smp

What Are The Drivers Pushing New Developments In The Oral Solid Dosage Pharmaceutical Formulation Market?

The escalating incidence of chronic illnesses is anticipated to fuel the expansion of the oral solid dosage pharmaceutical formulation market moving forward. Chronic diseases are defined as persistent health conditions that endure for an extended duration, typically three months or longer. Their rise is attributed to various factors such as aging populations, inactive lifestyles, unhealthy eating habits, environmental elements, and advancements in detection and diagnostic methodologies. Oral solid dosage pharmaceutical formulations play a vital role in managing chronic diseases and promoting adherence to long-term treatments, owing to their convenience, stability, and precise dosing. For illustration, in February 2024, the World Health Organization, an intergovernmental organization located in Switzerland, projected over 35 million new cancer cases by 2050, marking a 77% increase compared to the estimated 20 million cases in 2022. Thus, the increasing occurrence of chronic diseases is a key factor driving the growth of the oral solid dosage pharmaceutical formulation market.

Which Key Segments Fueling The Oral Solid Dosage Pharmaceutical Formulation Market?

The oral solid dosage pharmaceutical formulation market covered in this report is segmented –

1) By Dosage Form: Tablets, Capsules, Powders And Granules, Lozenges And Pastilles, Gummies

2) By Mechanism: Controlled-Release, Immediate-Release, Delayed-Release

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Hypermarkets Or Supermarkets

4) By End-User: Large-Size Companies, Medium And Small-Size Companies, Other End-Users

Subsegments:

1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets, Controlled-Release Tablets, Effervescent Tablets, Chewable Tablets, Sublingual Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Liquid-Filled Capsules, Delayed-Release Capsules

3) By Powders And Granules: Oral Powders (Reconstitution), Granules (Oral Suspension Or Dispersible Granules)

4) By Lozenges And Pastilles: Medicinal Lozenges, Herbal Lozenges, Sugar-Free Lozenges, Pastilles ( Throat Or Cough Relief)

5) By Gummies: Vitamin Gummies, Herbal And Nutritional Supplement Gummies, Pharmaceutical Gummies ( Pain Relief Or Sleep Aids)

Which Ongoing Trends Are Expected To Shape The Oral Solid Dosage Pharmaceutical Formulation Market Outlook?

Leading companies active in the oral solid dosage pharmaceutical formulation market are creating innovative products, like liquid-filled capsules, aimed at improving drug delivery, enhancing bioavailability, and offering more convenient dosing alternatives for patients. Liquid-filled capsules are oral dosage forms composed of a gelatin shell filled with a liquid or semi-solid formulation containing active pharmaceutical ingredients (APIs) and excipients. As an example, in July 2023, Zeon Lifesciences Ltd., an India-based pharmaceutical company, launched liquid-filled capsules, providing a cutting-edge delivery system with improved bioavailability and absorption rates. These capsules feature an inventive delivery system that boosts bioavailability and absorption, ensuring optimal active ingredient levels for maximum effectiveness and immediate outcomes. Zeon’s liquid-filled capsules deliver precise and consistent dosages, thereby enhancing patient compliance and their control over medication administration. These capsules leverage advanced technologies to improve bioavailability, lead to better patient outcomes, and protect the medication’s integrity. Zeon’s liquid-filled capsules present a convenient, effective, and reliable alternative to conventional dosage forms, setting a new standard for patient care and compliance within the pharmaceutical industry.

Which Major Industry Participants Are Leading The Oral Solid Dosage Pharmaceutical Formulation Market Growth?

Major companies operating in the oral solid dosage pharmaceutical formulation market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca Plc., Novartis AG, Hoffman-La-Roche Ltd., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim GmbH, Gilead Sciences, Amgen Inc., Teva Pharmaceuticals, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Biogen Inc., Lonza Group, Catalent Inc., Ashland Inc., Piramal Pharma Solutions, Jubilant Pharmova, CordenPharma International

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-pharmaceutical-formulation-global-market-report

What Are The Key Regional Factors Influencing The Oral Solid Dosage Pharmaceutical Formulation Market Growth?

North America was the largest region in the oral solid dosage pharmaceutical formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral solid dosage pharmaceutical formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Oral Solid Dosage Pharmaceutical Formulation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15626&type=smp

Browse Through More Reports Similar to the Global Oral Solid Dosage Pharmaceutical Formulation Market 2025, By The Business Research Company

Oral Biologics And Biosimilars Market 2025

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-market

Oral Biologics And Biosimilar Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilar-drug-global-market-report

Oral Contraceptive Pills Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795